Literature DB >> 16638547

Surgery for pulmonary venous obstruction after repair of total anomalous pulmonary venous return.

François Lacour-Gayet1.   

Abstract

The major complication and the main cause of reoperation following surgery for total anomalous pulmonary venous return (TAPVR) is the occurrence of pulmonary venous obstruction. Outcomes after surgical repair of TAPVR have greatly improved in the last 10 years; however, the complex forms of TAPVR, particularly when associated with single ventricle and heterotaxy, still carry a high risk of failure. The pathology of pulmonary venous obstruction following TAPVR surgery is a fibrous intimal hyperplasia associated with some medial hypertrophy. There is an increasing severity in the spectrum of lesions from anastomotic stricture to pulmonary vein ostial stenosis and diffuse pulmonary vein stenosis. For anastomotic lesions, revision of the TAPVR anastomosis by patch enlargement of the left atrial anastomosis provides good results. On the contrary, conventional techniques in cases of pulmonary vein ostial stenosis had very poor results. The sutureless repair technique introduced in 1996 provides better midterm results than any other technique, with freedom from mortality and recurrence improving from 65% to 90%. The sutureless technique is described in detail, with emphasis on the need for resection of the pulmonary vein scar tissue and on the different techniques needed respectively on the right and the left side. In our experience, using an atraumatic technique at the initial repair has greatly decreased the occurrence of late pulmonary venous obstruction.

Entities:  

Mesh:

Year:  2006        PMID: 16638547     DOI: 10.1053/j.pcsu.2006.02.010

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu        ISSN: 1092-9126


  7 in total

Review 1.  Current topics in surgery for isolated total anomalous pulmonary venous connection.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Yoshinori Doki; Katsunori Takeuchi; Tomonori Higuma; Kazutaka Senda; Masayoshi Toge; Tatsuro Matsuo; Saori Nagura; Masaya Aoki; Kimimasa Sakata; Hayato Obi
Journal:  Surg Today       Date:  2014-03-16       Impact factor: 2.549

2.  Management of pulmonary venous obstruction.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Yoshinori Doki; Toshio Doi; Katsunori Takeuchi; Tomonori Higuma; Kazutaka Senda; Masayoshi Toge; Saori Nagura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-10-03

Review 3.  Surgery for total anomalous pulmonary venous connection: primary sutureless repair vs. conventional repair.

Authors:  Naoki Yoshimura; Kazuaki Fukahara; Akio Yamashita; Toshio Doi; Katsunori Takeuchi; Shigeyuki Yamashita; Takahiro Homma; Shigeki Yokoyama; Masaya Aoki; Yuki Ikeno
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-03-22

4.  Peripheral Blood Transcripts Predict Preoperative Obstructive Total Anomalous Pulmonary Venous Connection.

Authors:  Zunmin Wan; Xiaohong Li; Jinghua Sun; Xiaohua Li; Zhongzhen Liu; Haojian Dong; Qing Zhou; Hailong Qiu; Jinjin Xu; Tingyu Yang; Wen-Jing Wang; Yanqiu Ou
Journal:  Front Cardiovasc Med       Date:  2022-05-31

5.  Bronchoscopic diagnosis of asymptomatic unilateral pulmonary vein atresia in an infant.

Authors:  Cécile Tissot; Regula Corbelli; Yacine Aggoun; Maurice Beghetti; Eduardo da Cruz
Journal:  Pediatr Cardiol       Date:  2007-11-17       Impact factor: 1.655

6.  Prostaglandin e1 on infradiaphragmatic type of total anomalous pulmonary venous connection - a case report.

Authors:  Catalin Cirstoveanu; Eliza Cinteza; Veronica Marcu; Mihaela Bizubac; Alina Balomir; Ileana Barascu; Mariana Coman; Mihaela Balgradean
Journal:  Maedica (Buchar)       Date:  2012-06

7.  Why can pulmonary vein stenoses created by radiofrequency catheter ablation worsen during and after follow-up? A potential explanation.

Authors:  Pierre-André Doriot; Pierre-André Dorsaz; Dipen Chandrakant Shah
Journal:  J Cardiothorac Surg       Date:  2008-05-05       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.